遺伝性血管浮腫治療の世界市場レポート2020

• 英文タイトル：Global Hereditary Angioedema Treatment Sales Market Report 2020

• レポートコード：QY20ST-08044 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥580,000 (USD4,000)	▷ お問い合わせ
Multi User	￥870,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,160,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、世界の遺伝性血管浮腫治療市場について種類別（C1エステラーゼ阻害剤（プラズマ製品、組換え製品）、選択的ブラジキニンB2受容体拮抗薬（Firazyr）、カリクレイン阻害剤（カルビトール、タクシロ）、その他（従来薬、パイプライン薬））、用途別（ Hospital Pharmacies Retail Pharmacies Others (online pharmacies, mail pharmacies) ）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・遺伝性血管浮腫治療市場の概要 ・世界の主要地域別遺伝性血管浮腫治療市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の遺伝性血管浮腫治療市場規模2015-2026：種類別（C1エステラーゼ阻害剤（プラズマ製品、組換え製品）、選択的ブラジキニンB2受容体拮抗薬（Firazyr）、カリクレイン阻害剤（カルビトール、 タクシロ）、その他（従来薬、パイプライン薬）） ・世界の遺伝性血管浮腫治療市場規模2015-2026：用途別（ Hospital Pharmacies Retail Pharmacies Others (online pharmacies, mail pharmacies) ） ・遺伝性血管浮腫治療の北米市場規模2015-2020 ・遺伝性血管浮腫治療のヨーロッパ市場規模2015-2020 ・遺伝性血管浮腫治療の中国市場規模2015-2020 ・遺伝性血管浮腫治療の日本市場規模2015-2020 ・遺伝性血管浮腫治療の東南アジア市場規模2015-2020 ・遺伝性血管浮腫治療のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・遺伝性血管浮腫治療の製造コスト分析 ・販売チャネル、流通業者、顧客 ・遺伝性血管浮腫治療の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Hereditary Angioedema Treatment Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Hereditary Angioedema Treatment market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Hereditary Angioedema Treatment industry.
Based on our recent survey, we have several different scenarios about the Hereditary Angioedema Treatment YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Hereditary Angioedema Treatment will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Hereditary Angioedema Treatment Scope and Market Size
The global Hereditary Angioedema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hereditary Angioedema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hereditary Angioedema Treatment market is segmented into
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)

Segment by Application, the Hereditary Angioedema Treatment market is segmented into
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)

The Hereditary Angioedema Treatment market is analysed and market size information is provided by regions (countries). Segment by Application, the Hereditary Angioedema Treatment market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Hereditary Angioedema Treatment Market Share Analysis
Hereditary Angioedema Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hereditary Angioedema Treatment business, the date to enter into the Hereditary Angioedema Treatment market, Hereditary Angioedema Treatment product introduction, recent developments, etc.

The major vendors covered:
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
…

レポート目次

---

1 Hereditary Angioedema Treatment Market Overview
1.1 Hereditary Angioedema Treatment Product Scope
1.2 Hereditary Angioedema Treatment Segment by Type
1.2.1 Global Hereditary Angioedema Treatment Sales by Type (2020-2026)
1.2.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.2.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.2.4 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.2.5 Others (Conventional Drugs, Pipeline Drugs)
1.3 Hereditary Angioedema Treatment Segment by Application
1.3.1 Global Hereditary Angioedema Treatment Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others (online pharmacies, mail pharmacies)
1.4 Hereditary Angioedema Treatment Market Estimates and Forecasts (2015-2026)
1.4.1 Global Hereditary Angioedema Treatment Sales Growth Rate (2015-2026)
1.4.2 Global Hereditary Angioedema Treatment Revenue and Growth Rate (2015-2026)
1.4.3 Global Hereditary Angioedema Treatment Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
1.5.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry
1.5.1.1 Hereditary Angioedema Treatment Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact

2 Hereditary Angioedema Treatment Estimate and Forecast by Region
2.1 Global Hereditary Angioedema Treatment Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Hereditary Angioedema Treatment Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020)
2.2.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
2.3 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Hereditary Angioedema Treatment Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Hereditary Angioedema Treatment Estimates and Projections (2015-2026)
2.4.2 Europe Hereditary Angioedema Treatment Estimates and Projections (2015-2026)
2.4.3 China Hereditary Angioedema Treatment Estimates and Projections (2015-2026)
2.4.4 Japan Hereditary Angioedema Treatment Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Hereditary Angioedema Treatment Estimates and Projections (2015-2026)
2.4.6 India Hereditary Angioedema Treatment Estimates and Projections (2015-2026)
3 Global Hereditary Angioedema Treatment Competition Landscape by Players
3.1 Global Top Hereditary Angioedema Treatment Players by Sales (2015-2020)
3.2 Global Top Hereditary Angioedema Treatment Players by Revenue (2015-2020)
3.3 Global Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Treatment as of 2019)
3.4 Global Hereditary Angioedema Treatment Average Price by Company (2015-2020)
3.5 Manufacturers Hereditary Angioedema Treatment Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Hereditary Angioedema Treatment Players (Opinion Leaders)
4 Global Hereditary Angioedema Treatment Market Size by Type
4.1 Global Hereditary Angioedema Treatment Historic Market Review by Type (2015-2020)
4.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
4.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Type (2015-2020)
4.1.3 Global Hereditary Angioedema Treatment Price by Type (2014-2020)
4.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Global Hereditary Angioedema Treatment Price Forecast by Type (2021-2026)
5 Global Hereditary Angioedema Treatment Market Size by Application
5.1 Global Hereditary Angioedema Treatment Historic Market Review by Application (2015-2020)
5.1.1 Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
5.1.2 Global Hereditary Angioedema Treatment Revenue Market Share by Application (2015-2020)
5.1.3 Global Hereditary Angioedema Treatment Price by Application (2015-2020)
5.2 Global Hereditary Angioedema Treatment Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Hereditary Angioedema Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Hereditary Angioedema Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Hereditary Angioedema Treatment Price Forecast by Application (2021-2026)

3 North America Hereditary Angioedema Treatment Market Facts & Figures
3.2 North America Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
3.3 North America Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
3.4 North America Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)

4 Europe Hereditary Angioedema Treatment Market Facts & Figures
4.2 Europe Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
4.3 Europe Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
4.4 Europe Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)

5 China Hereditary Angioedema Treatment Market Facts & Figures
5.2 China Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
5.3 China Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
5.4 China Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)

6 Japan Hereditary Angioedema Treatment Market Facts & Figures
6.2 Japan Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
6.3 Japan Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
6.4 Japan Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)

7 Southeast Asia Hereditary Angioedema Treatment Market Facts & Figures
7.2 Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)

8 India Hereditary Angioedema Treatment Market Facts & Figures
8.2 India Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
8.3 India Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
8.4 India Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Hereditary Angioedema Treatment Business
12.1 CSL
12.1.1 CSL Hereditary Angioedema Treatment Corporation Information
12.1.2 CSL Hereditary Angioedema Treatment Business Overview and Total Revenue
12.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Hereditary Angioedema Treatment Products Offered
12.1.5 CSL Recent Development
12.2 Pharming Group
12.2.1 Pharming Group Hereditary Angioedema Treatment Corporation Information
12.2.2 Pharming Group Hereditary Angioedema Treatment Business Overview and Total Revenue
12.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
12.2.5 Pharming Group Recent Development
12.3 Shire plc (Takeda Pharmaceutical Company Limited)
12.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Corporation Information
12.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Business Overview and Total Revenue
12.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
12.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
12.4 Ionis Pharmaceuticals
12.4.1 Ionis Pharmaceuticals Hereditary Angioedema Treatment Corporation Information
12.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Business Overview and Total Revenue
12.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.4.5 Ionis Pharmaceuticals Recent Development
12.5 Attune Pharmaceuticals
12.5.1 Attune Pharmaceuticals Hereditary Angioedema Treatment Corporation Information
12.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Business Overview and Total Revenue
12.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.5.5 Attune Pharmaceuticals Recent Development
12.6 BioCryst Pharmaceuticals
12.6.1 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Corporation Information
12.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Business Overview and Total Revenue
12.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.6.5 BioCryst Pharmaceuticals Recent Development
12.7 KalVista Pharmaceuticals
12.7.1 KalVista Pharmaceuticals Hereditary Angioedema Treatment Corporation Information
12.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Business Overview and Total Revenue
12.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2015-2020)
12.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
12.7.5 KalVista Pharmaceuticals Recent Development
…

13 Hereditary Angioedema Treatment Manufacturing Cost Analysis
13.1 Hereditary Angioedema Treatment Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hereditary Angioedema Treatment
13.4 Hereditary Angioedema Treatment Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hereditary Angioedema Treatment Distributors List
14.3 Hereditary Angioedema Treatment Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Hereditary Angioedema Treatment Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Hereditary Angioedema Treatment Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Hereditary Angioedema Treatment Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Hereditary Angioedema Treatment Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Hereditary Angioedema Treatment Players to Combat Covid-19 Impact
Table 8. Global Market Hereditary Angioedema Treatment Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Hereditary Angioedema Treatment Sales (K Units) by Region (2015-2020)
Table 10. Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2020)
Table 11. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Hereditary Angioedema Treatment Revenue Share by Region (2015-2020)
Table 13. Global Hereditary Angioedema Treatment Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Hereditary Angioedema Treatment Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Hereditary Angioedema Treatment Revenue Share Forecast by Region (2021-2026)
Table 17. Global Hereditary Angioedema Treatment (K Units) of Key Companies (2015-2020)
Table 18. Global Hereditary Angioedema Treatment Sales Share by Company (2015-2020)
Table 19. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Hereditary Angioedema Treatment Revenue Share by Company (2015-2020)
Table 21. Global Hereditary Angioedema Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hereditary Angioedema Treatment as of 2019)
Table 22. Global Hereditary Angioedema Treatment Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Hereditary Angioedema Treatment Manufacturing Sites and Area Served
Table 24. Manufacturers Hereditary Angioedema Treatment Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Hereditary Angioedema Treatment Players
Table 27. Global Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 28. Global Hereditary Angioedema Treatment Sales Share by Type (2015-2020)
Table 29. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Hereditary Angioedema Treatment Price (K Units) by Type (2015-2020)
Table 31. Global Hereditary Angioedema Treatment Sales Share by Type (2021-2026)
Table 32. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Hereditary Angioedema Treatment Revenue Share by Type (2021-2026)
Table 34. Global Hereditary Angioedema Treatment Price (K Units) by Type (2021-2026)
Table 35. Global Hereditary Angioedema Treatment Sales (K Units) by Application (2015-2020)
Table 36. Global Hereditary Angioedema Treatment Sales Share by Application (2015-2020)
Table 37. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Hereditary Angioedema Treatment Price (K Units) by Application (2015-2020)
Table 39. Global Hereditary Angioedema Treatment Sales (K Units) by Application (2021-2026)
Table 40. Global Hereditary Angioedema Treatment Sales Share by Application (2021-2026)
Table 41. Global Hereditary Angioedema Treatment Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Hereditary Angioedema Treatment Revenue Share by Application (2021-2026)
Table 43. Global Hereditary Angioedema Treatment Price (K Units) by Application (2021-2026)
Table 44. United States Hereditary Angioedema Treatment Sales (K Units) by Company (2015-2020)
Table 45. United States Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
Table 46. United States Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 47. United States Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 48. United States Hereditary Angioedema Treatment Sales (K Units) by Application (2015-2020)
Table 49. United States Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 50. Europe Hereditary Angioedema Treatment Sales (K Units) by Company (2015-2020)
Table 51. Europe Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
Table 52. Europe Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 53. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 54. Europe Hereditary Angioedema Treatment Sales (K Units) by Application (2015-2020)
Table 55. Europe Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 56. China Hereditary Angioedema Treatment Sales (K Units) by Company (2015-2020)
Table 57. China Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
Table 58. China Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 59. China Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 60. China Hereditary Angioedema Treatment Sales (K Units) by Application (2015-2020)
Table 61. China Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 62. Japan Hereditary Angioedema Treatment Sales (K Units) by Company (2015-2020)
Table 63. Japan Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
Table 64. Japan Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 65. Japan Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 66. Japan Hereditary Angioedema Treatment Sales (K Units) by Application (2015-2020)
Table 67. Japan Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Hereditary Angioedema Treatment Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 74. India Hereditary Angioedema Treatment Sales (K Units) by Company (2015-2020)
Table 75. India Hereditary Angioedema Treatment Sales Market Share by Company (2015-2020)
Table 76. India Hereditary Angioedema Treatment Sales (K Units) by Type (2015-2020)
Table 77. India Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Table 78. India Hereditary Angioedema Treatment Sales (K Units) by Application (2015-2020)
Table 79. India Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. CSL Hereditary Angioedema Treatment Product
Table 84. CSL Recent Development
Table 85. Pharming Group Corporation Information
Table 86. Pharming Group Description and Business Overview
Table 87. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pharming Group Hereditary Angioedema Treatment Product
Table 89. Pharming Group Recent Development
Table 90. Shire plc (Takeda Pharmaceutical Company Limited) Corporation Information
Table 91. Shire plc (Takeda Pharmaceutical Company Limited) Description and Business Overview
Table 92. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product
Table 94. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table 95. Ionis Pharmaceuticals Corporation Information
Table 96. Ionis Pharmaceuticals Description and Business Overview
Table 97. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product
Table 99. Ionis Pharmaceuticals Recent Development
Table 100. Attune Pharmaceuticals Corporation Information
Table 101. Attune Pharmaceuticals Description and Business Overview
Table 102. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Attune Pharmaceuticals Hereditary Angioedema Treatment Product
Table 104. Attune Pharmaceuticals Recent Development
Table 105. BioCryst Pharmaceuticals Corporation Information
Table 106. BioCryst Pharmaceuticals Description and Business Overview
Table 107. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product
Table 109. BioCryst Pharmaceuticals Recent Development
Table . KalVista Pharmaceuticals Corporation Information
Table . KalVista Pharmaceuticals Description and Business Overview
Table . KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . KalVista Pharmaceuticals Hereditary Angioedema Treatment Product
Table . KalVista Pharmaceuticals Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Hereditary Angioedema Treatment Distributors List
Table 118. Hereditary Angioedema Treatment Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereditary Angioedema Treatment Product Picture
Figure 2. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hereditary Angioedema Treatment Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Others (online pharmacies, mail pharmacies) Examples
Figure 9. Global Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Hereditary Angioedema Treatment Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Hereditary Angioedema Treatment Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Hereditary Angioedema Treatment Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Hereditary Angioedema Treatment Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Hereditary Angioedema Treatment Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Hereditary Angioedema Treatment Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Hereditary Angioedema Treatment Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Hereditary Angioedema Treatment Players Market Share by Revenue in Hereditary Angioedema Treatment 2015 & 2019
Figure 27. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Hereditary Angioedema Treatment Revenue Share by Type (2015-2020)
Figure 29. Global Hereditary Angioedema Treatment Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Hereditary Angioedema Treatment Revenue Share by Application (2015-2020)
Figure 31. Global Hereditary Angioedema Treatment Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 33. United States Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 34. Europe Hereditary Angioedema Treatment Sales Market Share by Company in 2019
Figure 35. Europe Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 36. Europe Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 37. China Hereditary Angioedema Treatment Sales Market Share by Company in 2019
Figure 38. China Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 39. China Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 40. Japan Hereditary Angioedema Treatment Sales Market Share by Company in 2019
Figure 41. Japan Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 42. Japan Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 43. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Company in 2019
Figure 44. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 45. Southeast Asia Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 46. India Hereditary Angioedema Treatment Sales Market Share by Company in 2019
Figure 47. India Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Figure 48. India Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure 49. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pharming Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Shire plc (Takeda Pharmaceutical Company Limited) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Ionis Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Attune Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. BioCryst Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. KalVista Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Hereditary Angioedema Treatment
Figure 58. Manufacturing Process Analysis of Hereditary Angioedema Treatment
Figure 59. Hereditary Angioedema Treatment Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

---